Colonoscopy is the most widely used screening test for colon cancer, which is among the most commonly diagnosed cancers. More than 50,000 Americans die from the disease every year. Colon cancer almost always begins as abnormal growths called polyps, which can be detected and removed during a colonoscopy, dramatically lowering your risk of developing the disease.
ACG President Dr. Harry Sarles is interviewed. Reader’s Digest (2/18)
Nearly a year ago, Mark Smith, a 27-year-old doctoral candidate, and three colleagues launched OpenBiome, the nation’s first human stool bank. Its mission: to provide doctors with safe, inexpensive fecal material from screened donors to treat patients with Clostridium difficile, a gastrointestinal infection that kills at least 14,000 Americans a year. New York Times (2/17)
Survival rates for white and Asian patients with advanced colon cancer have improved significantly, but the benefits haven’t extended to blacks and Hispanics, according to an American Cancer Society study. Healthday News (2/14)
The increased frequency and rising costs associated with constipation diagnoses represent an escalating burden on the health care system, according to new data published in the American Journal of Gastroenterology. Healio (2/11)
In recent study published in the American Journal of Gastroenterology, researchers examined the effect of bowel cleanse quality on adherence to the recommendation. The researchers examined quality of colon cleansing among 1,387 follow-up colonoscopy patients. Becker’s ASC (2/10)
Quinoa was well-tolerated by the patients and did not worsen their condition, according to the findings published Jan. 21 in The American Journal of Gastroenterology.
Doctors today have to rely on X-ray scans and patients’ descriptions of their symptoms to diagnose irritable bowel syndrome (IBS). But scientists at the University of Nottingham’s Digestive Diseases Centre in the U.K. have discovered a new way of investigating the illness using MRIs, which could affect how doctors diagnose and treat IBS in the future. Yahoo Health (1/15)
Value-based care is a term heard across all specialties in healthcare, but value is an abstract term. Physicians, payers and patients each have a stake in defining value-based care and what it means for the future of healthcare. Becker’s (1/15)
Anti-tumor necrosis factor agents like infliximab (Remicade) were not associated with risks for cancer in patients with Crohn’s disease, researchers found. Medscape (1/10)
Current guidelines for detecting undiagnosed celiac disease (CD) are inadequate for widespread CD screening, according to results from a study published online January 13 in Pediatrics. Medscape (1/13)